查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946645

2026年全球癌症分子診斷市場報告

Oncology Molecular Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，腫瘤分子診斷市場發展迅速，預計將從2025年的56.5億美元成長到2026年的63.4億美元，複合年成長率達12.2%。過去幾年成長要素包括癌症發生率的上升、PCR和定序技術的廣泛應用、腫瘤研究經費的增加、醫院診斷服務的擴展以及分子檢測的監管核准。

預計未來幾年腫瘤分子診斷市場將快速成長，到2030年市場規模將達到101.3億美元，複合年成長率（CAGR）為12.4%。預測期內的成長要素包括精準腫瘤學的應用、液態生物檢體技術的進步、對個人化治療的需求、人工智慧賦能的數據分析以及新興市場的滲透。預測期內的主要趨勢包括伴隨診斷的成長、液態生物檢體應用的增加、基於生物標記的檢測的擴展、癌症篩檢項目數量的增加以及對早期精準癌症檢測的需求。

對個人化醫療日益成長的需求將進一步推動腫瘤分子診斷市場的未來擴張。個人化醫療專注於根據患者的個別特徵（包括基因組成和疾病譜）量身定做的醫療方案和干涉措施。分子腫瘤診斷在個人化癌症治療中發揮重要作用，它能夠實現精準的腫瘤分析、最佳化藥物選擇和製定個人化的治療策略，從而改善臨床療效和患者生活品質。例如，根據美國非營利組織「個人化醫療聯盟」（Personalized Medicine Alliance）統計，截至2024年2月，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病患者的新型個人化療法，高於2022年的6種。個人化醫療的不斷普及正在推動腫瘤分子診斷市場的發展。

腫瘤分子診斷市場的關鍵參與者正在推動基因組技術的發展，例如新一代基因測序、計算分析和創新腫瘤建模，以改善癌症早期檢測、突變識別和個人化治療策略。這些進步提高了診斷準確性，加快了結果出爐速度，並滿足了社區對高精度分子檢測日益成長的需求。例如，2024年5月，總部位於加拿大的精準腫瘤學服務供應商OncoHelix-CoLab與阿拉伯聯合大公國布爾吉爾控股公司合作，在阿拉伯聯合大公國布爾吉爾醫療城開設了一家最先進的實驗室。該實驗室將能夠進行本地化的先進分子和免疫學檢測，增強區域診斷能力，並透過夥伴關係（例如ClarityDX前列腺癌檢測）支援多種癌症類型的檢測，包括前列腺癌。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球癌症分子診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 身臨其境型技術（AR/VR/XR）與數位體驗
  • 主要趨勢
    • 伴隨診斷的發展
    • 液態生物檢體的應用日益廣泛
    • 擴大基於生物標記的檢測
    • 增加癌症篩檢項目
    • 對早期準確癌症檢測的需求

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷中心
  • 學術機構
  • 研究所
  • 癌症診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球癌症分子診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球癌症分子診斷市場規模、比較及成長率分析
  • 全球癌症分子診斷市場表現：規模與成長，2020-2025年
  • 全球癌症分子診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 設備、試劑及其他產品
  • 透過技術
  • 聚合酵素鏈鎖反應（PCR）、原位雜合反應（ISH）、恒溫核酸增幅技術（INNAT）、晶片和微陣列、定序、質譜分析、轉錄媒介增幅（TMA）以及其他技術
  • 最終用戶
  • 醫院、診斷中心、學術研究機構和其他最終用戶
  • 按類型細分：設備
  • 聚合酵素鏈鎖反應（PCR）儀、定序儀、微陣列平台和螢光原位雜合反應（FISH）儀
  • 按類型細分：試劑
  • DNA與RNA萃取試劑盒、PCR試劑與試劑盒、NGS樣品製備試劑盒、診斷檢測試劑
  • 按類型細分：其他產品
  • 數據分析與解釋軟體、品管及校準產品、耗材、腫瘤檢測用生物標記

第10章 區域與國家分析

  • 全球癌症分子診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球癌症分子診斷市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 癌症分子診斷市場：競爭格局及市場佔有率（2024年）
  • 癌症分子診斷市場：公司估值矩陣
  • 癌症分子診斷市場：公司概況
    • F. Hoffmann-La Roche AG
    • Bayer AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第37章：其他領先和創新企業

  • Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年癌症分子診斷市場：提供新機會的國家
  • 2030年癌症分子診斷市場：蘊藏新機會的細分市場
  • 2030年癌症分子診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME6MOMDO01_G26Q1

Oncology molecular diagnostics involve tests that analyze genes, proteins, and related molecules to diagnose cancers and guide treatment decisions.

The primary products in the oncology molecular diagnostics market include instruments, reagents, and others. Oncology molecular diagnostic instruments are utilized for the detection and diagnosis of cancer. The technologies involved include polymerase chain reaction (PCR), in-situ hybridization (ISH), isothermal nucleic acid amplification technology (INNAT), chips and microarrays, sequencing, mass spectrometry, transcription-mediated amplification (TMA), and others. These products are used by end users such as hospitals, diagnostic centers, academic institutions, research organizations, and others.

Tariffs are impacting the oncology molecular diagnostics market by increasing costs of imported sequencing instruments, reagents, and analytical software components. Reagents and instruments segments are most impacted, especially in North America and Asia-Pacific where advanced diagnostics are widely deployed. Elevated costs may delay technology upgrades for diagnostic centers. Conversely, tariffs are encouraging regional manufacturing, domestic reagent production, and strategic collaborations to reduce dependency on imports.

The oncology molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides oncology molecular diagnostics market statistics, including oncology molecular diagnostics industry global market size, regional shares, competitors with a oncology molecular diagnostics market share, detailed oncology molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the oncology molecular diagnostics industry. This oncology molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncology molecular diagnostics market size has grown rapidly in recent years. It will grow from $5.65 billion in 2025 to $6.34 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing cancer prevalence, adoption of PCR and sequencing, oncology research funding, hospital diagnostic expansion, regulatory approvals for molecular tests.

The oncology molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to precision oncology adoption, liquid biopsy advancements, personalized treatment demand, AI-driven data interpretation, emerging market penetration. Major trends in the forecast period include growth in companion diagnostics, rising use of liquid biopsy, expansion of biomarker-based testing, increasing cancer screening programs, demand for early and accurate cancer detection.

The increasing demand for personalized medicine is increasingly supporting the expansion of the oncology molecular diagnostics market going forward. Personalized medicine focuses on tailoring medical treatments and interventions to individual patient characteristics, including genetic makeup and disease profiles. Oncology molecular diagnostics play a critical role in personalized cancer care by enabling precise tumor profiling, optimized drug selection, and individualized treatment strategies that improve clinical outcomes and patient quality of life. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. Consequently, the rising adoption of personalized medicine is strengthening the oncology molecular diagnostics market.

Leading companies operating in the oncology molecular diagnostics market are advancing genomics technologies such as next-generation cancer genome sequencing, computational analytics, and innovative tumor modeling to improve early cancer detection, mutation identification, and personalized treatment strategies. These advancements enhance diagnostic accuracy, reduce turnaround times, and address growing demand for localized, high-precision molecular testing. For example, in May 2024, OncoHelix-CoLab, a Canada-based precision oncology provider, launched a state-of-the-art laboratory at Burjeel Medical City in the UAE through a collaboration with Burjeel Holdings. The facility enables advanced molecular and immunology testing to be performed locally, strengthening regional diagnostic capabilities and supporting assays for multiple cancers, including prostate cancer through partnerships such as its collaboration on the ClarityDX Prostate test.

In June 2023, INEX Innovate Pte Ltd., a Singapore-based molecular diagnostic technology company, acquired Yourgene Health (Taiwan) Co., Ltd. for an undisclosed amount. Through this acquisition, INEX Innovate aims to strengthen its capabilities in fetal health, oncology research and development, and bioinformatics. Yourgene Health is a Taiwan-based genomics company and international molecular diagnostics group expanding its genetic testing portfolio to include oncology applications.

Major companies operating in the oncology molecular diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Genomic Health Inc.

North America was the largest region in the oncology molecular diagnostics market in 2025. Western Europe was the second largest region in the global oncology molecular diagnostics market report. The regions covered in the oncology molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The oncology molecular diagnostics market includes revenues earned by oncology molecular diagnostics tools and kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncology Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oncology molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Instruments; Reagents; Other Products
  • 2) By Technology: Polymerase Chain Reaction (PCR); In-Situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips And Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Other Technologies
  • 3) By End User: Hospitals; Diagnostic Centers; Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Platforms; Fluorescence In Situ Hybridization (FISH) Instruments
  • 2) By Reagents: DNA And RNA Extraction Kits; PCR Reagents And Kits; NGS Library Preparation Kits; Diagnostic Assay Reagents
  • 3) By Other Products: Software For Data Analysis And Interpretation; Quality Control And Calibration Products; Consumables; For Molecular Testing; Biomarkers For Oncology Testing
  • Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthcare AG; Becton Dickinson and Company; Agilent Technologies Inc.; HTG Molecular Diagnostics Inc.; Hologic Inc.; Illumina Inc.; bioMerieux SA; Beckman Coulter Inc.; Sysmex Corporation; Bio-Rad Laboratories Inc.; Qiagen N.V.; Exact Sciences Corp.; Bio-Techne Corporation; OPKO Health Inc.; Myriad Genetics Inc.; Guardant Health AMEA; Veracyte Inc.; Adaptive Biotechnologies Corp.; Foundation Medicine Inc.; Pacific Biosciences of California Inc.; NanoString Technologies Inc.; Genomic Health Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Oncology Molecular Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Oncology Molecular Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Oncology Molecular Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Oncology Molecular Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
  • 4.2. Major Trends
    • 4.2.1 Growth In Companion Diagnostics
    • 4.2.2 Rising Use Of Liquid Biopsy
    • 4.2.3 Expansion Of Biomarker-Based Testing
    • 4.2.4 Increasing Cancer Screening Programs
    • 4.2.5 Demand For Early And Accurate Cancer Detection

5. Oncology Molecular Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centers
  • 5.3 Academic Institutes
  • 5.4 Research Laboratories
  • 5.5 Cancer Specialty Clinics

6. Oncology Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oncology Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Oncology Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Oncology Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Oncology Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Oncology Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oncology Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oncology Molecular Diagnostics Market Segmentation

  • 9.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Reagents, Other Products
  • 9.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips And Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies
  • 9.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Centers, Academic And Research Institutes, Other End Users
  • 9.4. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Platforms, Fluorescence In Situ Hybridization (FISH) Instruments
  • 9.5. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • DNA And RNA Extraction Kits, PCR Reagents And Kits, NGS Library Preparation Kits, Diagnostic Assay Reagents
  • 9.6. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software For Data Analysis And Interpretation, Quality Control And Calibration Products, Consumables, Biomarkers For Oncology Testing

10. Oncology Molecular Diagnostics Market Regional And Country Analysis

  • 10.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oncology Molecular Diagnostics Market

  • 11.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oncology Molecular Diagnostics Market

  • 12.1. China Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oncology Molecular Diagnostics Market

  • 13.1. India Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oncology Molecular Diagnostics Market

  • 14.1. Japan Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oncology Molecular Diagnostics Market

  • 15.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oncology Molecular Diagnostics Market

  • 16.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oncology Molecular Diagnostics Market

  • 17.1. South Korea Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oncology Molecular Diagnostics Market

  • 18.1. Taiwan Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oncology Molecular Diagnostics Market

  • 19.1. South East Asia Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oncology Molecular Diagnostics Market

  • 20.1. Western Europe Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oncology Molecular Diagnostics Market

  • 21.1. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oncology Molecular Diagnostics Market

  • 22.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oncology Molecular Diagnostics Market

  • 23.1. France Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oncology Molecular Diagnostics Market

  • 24.1. Italy Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oncology Molecular Diagnostics Market

  • 25.1. Spain Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oncology Molecular Diagnostics Market

  • 26.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oncology Molecular Diagnostics Market

  • 27.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oncology Molecular Diagnostics Market

  • 28.1. North America Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oncology Molecular Diagnostics Market

  • 29.1. USA Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oncology Molecular Diagnostics Market

  • 30.1. Canada Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oncology Molecular Diagnostics Market

  • 31.1. South America Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oncology Molecular Diagnostics Market

  • 32.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oncology Molecular Diagnostics Market

  • 33.1. Middle East Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oncology Molecular Diagnostics Market

  • 34.1. Africa Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oncology Molecular Diagnostics Market Regulatory and Investment Landscape

36. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Oncology Molecular Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Oncology Molecular Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Oncology Molecular Diagnostics Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Oncology Molecular Diagnostics Market Other Major And Innovative Companies

  • Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc.

38. Global Oncology Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

40. Oncology Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Oncology Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Oncology Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Oncology Molecular Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer